Freenome swings $254m investment
The funding comes as the company works to advance three clinical trials examining early cancer assessments across a few indications.
16 February 2024
16 February 2024
The funding comes as the company works to advance three clinical trials examining early cancer assessments across a few indications.
Amid ongoing human clinical trials, there is still a long way to go before neural chips are commonplace in clinics.
The TECNIS PureSee IOL is intended to offer high contrast and low-light performance on par with a monofocal intraocular lens (IOL).
The sale forms part of AngioDynamics' efforts to optimise its portfolio and restructure its manufacturing footprint.
The Seton-Scaffold device is designed to allow the fistula tract to drain and heal at the same time.
The T-Mode AI technology is currently available for aesthetics and plastic surgery applications with Clarius wireless scanners.
The German health investor will use its AI Earlybird Eagle Eye platform to scout out promising startups and gather crucial insights.
The French company has reported the first female patient implanted with the automated device met the trial’s primary endpoint.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.